| 000 | 01495cam a2200313 4500500 | ||
|---|---|---|---|
| 005 | 20250121154413.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aSmirnov, Artem _eauthor |
| 700 | 1 | 0 |
_a Anemona, Lucia _eauthor |
| 700 | 1 | 0 |
_a Montanaro, Manuela _eauthor |
| 700 | 1 | 0 |
_a Mauriello, Alessandro _eauthor |
| 700 | 1 | 0 |
_a Annicchiarico-Petruzzelli, Margherita _eauthor |
| 700 | 1 | 0 |
_a Campione, Elena _eauthor |
| 700 | 1 | 0 |
_a Melino, Gerry _eauthor |
| 700 | 1 | 0 |
_a Candi, Eleonora _eauthor |
| 245 | 0 | 0 | _aTransglutaminase 3 is expressed in basal cell carcinoma of the skin |
| 260 | _c2019. | ||
| 500 | _a75 | ||
| 520 | _aBackgroundTransglutaminase 3 (TG3) belongs to a family of Ca2+-dependent enzymes which catalyse protein crosslinking. TG3 is important for proper development of the skin and hair shaft, and knock-out mice for the Tgm3 gene are sensitive to UVB-induced photodamage due to aberrations in cornified envelope formation. Loss of TG3 is reported in head and neck and oesophageal squamous cell carcinoma, yet, its expression in skin cancer has not been studied. | ||
| 690 | _askin cancer | ||
| 690 | _asquamous cell carcinoma | ||
| 690 | _amelanoma | ||
| 690 | _atransglutaminase 3 | ||
| 690 | _akeratinocytes | ||
| 690 | _abasal cell carcinoma | ||
| 786 | 0 | _nEuropean Journal of Dermatology | 29 | 5 | 2019-09-01 | p. 477-483 | 1167-1122 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/revue-european-journal-of-dermatology-2019-5-page-477?lang=en&redirect-ssocas=7080 |
| 999 |
_c602178 _d602178 |
||